Robert M. Paris

Infectious Disease
22 S Greene St Ste 300
Baltimore, MD 21201

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

mRNA-based influenza vaccine expands the B cell response breadth in humans.

mRNA-based influenza vaccine expands the B cell response breadth in humans.

Journal: Nature immunology
Published: March 04, 2026

Post-vaccine inflammation tracking: validation of a novel individualized digital inflammatory biomarker relative to serum biomarkers.

Post-vaccine inflammation tracking: validation of a novel individualized digital inflammatory biomarker relative to serum biomarkers.

Journal: NPJ digital medicine
Published: October 16, 2025

Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunization.

Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunization.

Journal: Science immunology
Published: October 10, 2025

Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity.

Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity.

Journal: NPJ vaccines
Published: September 09, 2025

An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial.

An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial.

Journal: NPJ vaccines
Published: July 21, 2025

mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines.

mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines.

Journal: NPJ vaccines
Published: July 18, 2025

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta.

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta.

Journal: Cell reports
Published: January 10, 2025

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha crystalline beta.

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha crystalline beta.

Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025

Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein.

Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein.

Journal: bioRxiv : the preprint server for biology
Published: December 23, 2024

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase.

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase.

Journal: Nature communications
Published: December 19, 2024

mRNA-based influenza vaccine expands breadth of B cell response in humans.

mRNA-based influenza vaccine expands breadth of B cell response in humans.

Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study.

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study.

Journal: Frontiers in immunology
Published: September 24, 2024
Showing 1-12 of 58

Last Updated: 09/26/2026